Eli Lilly & Co. (LLY) Misses Q3 EPS by 7c

October 25, 2016 6:26 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $0.88, $0.07 worse than the analyst estimate of $0.95. Revenue for the quarter came in at $5.19 billion versus the consensus estimate of $5.29 billion.

Cialis revenue was $588.2 million. Est. at $594.7 million

Alinta revenue was $570.4 million, est at $551.7 million.

Eli Lilly & Co. reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities

Earnings

Add Your Comment